These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 20625814)
1. Relationship between diabetes and risk of second primary contralateral breast cancer. Li CI; Daling JR; Tang MT; Malone KE Breast Cancer Res Treat; 2011 Jan; 125(2):545-51. PubMed ID: 20625814 [TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor, progesterone receptor, and HER2-neu expression in first primary breast cancers and risk of second primary contralateral breast cancer. Saltzman BS; Malone KE; McDougall JA; Daling JR; Li CI Breast Cancer Res Treat; 2012 Oct; 135(3):849-55. PubMed ID: 22903686 [TBL] [Abstract][Full Text] [Related]
3. Second primary breast cancer occurrence according to hormone receptor status. Kurian AW; McClure LA; John EM; Horn-Ross PL; Ford JM; Clarke CA J Natl Cancer Inst; 2009 Aug; 101(15):1058-65. PubMed ID: 19590058 [TBL] [Abstract][Full Text] [Related]
4. Bisphosphonate use after estrogen receptor-positive breast cancer and risk of contralateral breast cancer. Monsees GM; Malone KE; Tang MT; Newcomb PA; Li CI J Natl Cancer Inst; 2011 Dec; 103(23):1752-60. PubMed ID: 22021667 [TBL] [Abstract][Full Text] [Related]
5. Use of Antihypertensive Medications Not Associated with Risk of Contralateral Breast Cancer among Women Diagnosed with Estrogen Receptor-Positive Invasive Breast Cancer. Chen L; Malone KE; Li CI Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1423-6. PubMed ID: 26084603 [TBL] [Abstract][Full Text] [Related]
6. Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population. Reiner AS; Lynch CF; Sisti JS; John EM; Brooks JD; Bernstein L; Knight JA; Hsu L; Concannon P; Mellemkjær L; Tischkowitz M; Haile RW; Shen R; Malone KE; Woods M; Liang X; Morrow M; Bernstein JL; Breast Cancer Res; 2017 Jul; 19(1):83. PubMed ID: 28724391 [TBL] [Abstract][Full Text] [Related]
7. Risk of contralateral breast cancer according to first breast cancer characteristics among women in the USA, 1992-2016. Ramin C; Withrow DR; Davis Lynn BC; Gierach GL; Berrington de González A Breast Cancer Res; 2021 Feb; 23(1):24. PubMed ID: 33596988 [TBL] [Abstract][Full Text] [Related]
8. Declining incidence of contralateral breast cancer in the United States from 1975 to 2006. Nichols HB; Berrington de González A; Lacey JV; Rosenberg PS; Anderson WF J Clin Oncol; 2011 Apr; 29(12):1564-9. PubMed ID: 21402610 [TBL] [Abstract][Full Text] [Related]
9. Hormone receptor status of contralateral breast cancers: analysis of data from the US SEER population-based registries. Mezencev R; Švajdler M Breast Cancer; 2017 May; 24(3):400-410. PubMed ID: 27502779 [TBL] [Abstract][Full Text] [Related]
10. Body mass index, weight change, and risk of second primary breast cancer in the WECARE study: influence of estrogen receptor status of the first breast cancer. Brooks JD; John EM; Mellemkjaer L; Lynch CF; Knight JA; Malone KE; Reiner AS; Bernstein L; Liang X; Shore RE; Stovall M; ; Bernstein JL Cancer Med; 2016 Nov; 5(11):3282-3291. PubMed ID: 27700016 [TBL] [Abstract][Full Text] [Related]
11. Reproductive history and risk of second primary breast cancer: the WECARE study. Largent JA; Capanu M; Bernstein L; Langholz B; Mellemkaer L; Malone KE; Begg CB; Haile RW; Lynch CF; Anton-Culver H; Wolitzer A; Bernstein JL Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):906-11. PubMed ID: 17507614 [TBL] [Abstract][Full Text] [Related]
12. Risk factors for contralateral breast cancer in Chennai (Madras), India. Gajalakshmi CK; Shanta V; Hakama M Int J Epidemiol; 1998 Oct; 27(5):743-50. PubMed ID: 9839728 [TBL] [Abstract][Full Text] [Related]
13. Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study. Langballe R; Mellemkjær L; Malone KE; Lynch CF; John EM; Knight JA; Bernstein L; Brooks J; Andersson M; Reiner AS; Liang X; Woods M; Concannon PJ; ; Bernstein JL Breast Cancer Res; 2016 Jul; 18(1):65. PubMed ID: 27400983 [TBL] [Abstract][Full Text] [Related]
14. Body mass index and risk of second primary breast cancer: the WECARE Study. Brooks JD; John EM; Mellemkjær L; Reiner AS; Malone KE; Lynch CF; Figueiredo JC; Haile RW; Shore RE; ; Bernstein JL; Bernstein L Breast Cancer Res Treat; 2012 Jan; 131(2):571-80. PubMed ID: 21892703 [TBL] [Abstract][Full Text] [Related]
15. Relationship between potentially modifiable lifestyle factors and risk of second primary contralateral breast cancer among women diagnosed with estrogen receptor-positive invasive breast cancer. Li CI; Daling JR; Porter PL; Tang MT; Malone KE J Clin Oncol; 2009 Nov; 27(32):5312-8. PubMed ID: 19738113 [TBL] [Abstract][Full Text] [Related]
16. Variation in the risk of radiation-related contralateral breast cancer by histology and estrogen receptor expression in SEER. Neta G; Anderson WF; Gilbert E; Berrington A Breast Cancer Res Treat; 2012 Feb; 131(3):1021-7. PubMed ID: 22015617 [TBL] [Abstract][Full Text] [Related]
17. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Gao X; Fisher SG; Emami B Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1038-45. PubMed ID: 12829139 [TBL] [Abstract][Full Text] [Related]
18. Age-related risk factors associated with primary contralateral breast cancer among younger women versus older women. Yoon TI; Kwak BS; Yi OV; Kim S; Um E; Yun KW; Shin HN; Lee S; Sohn G; Chung IY; Kim J; Ko BS; Lee JW; Son BH; Ahn SH; Kim HJ Breast Cancer Res Treat; 2019 Feb; 173(3):657-665. PubMed ID: 30377870 [TBL] [Abstract][Full Text] [Related]
19. Preoperative breast magnetic resonance imaging and contralateral breast cancer occurrence among older women with ductal carcinoma in situ. Wang SY; Long JB; Killelea BK; Evans SB; Roberts KB; Silber A; Gross CP Breast Cancer Res Treat; 2016 Jul; 158(1):139-148. PubMed ID: 27287780 [TBL] [Abstract][Full Text] [Related]
20. The association between physical health-related quality of life, physical functioning, and risk of contralateral breast cancer among older women. Mukand NH; Ko NY; Nabulsi NA; Hubbard CC; Chiu BC; Hoskins KF; Calip GS Breast Cancer; 2022 Mar; 29(2):287-295. PubMed ID: 34797467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]